Results 181 to 190 of about 292,213 (250)
Influence of the Gut Microbiota on Acute Ischemic Stroke Functional Outcomes at Three Months. [PDF]
Eur J NeurolLledós M, Prats-Sánchez L, Muiño E, Cullell N, Llucià-Carol L, Cárcel-Márquez J, Gallego-Fabrega C, Martín-Campos JM, Marín R, Aguilera-Simón A, Guasch-Jiménez M, Ezcurra-Díaz G, Camps-Renom P, Del Mar Freijo M, Martí-Fàbregas J, Fernández-Cadenas I. +15 moreeuropepmc +1 more sourceImmunosuppressed patients with COVID-19 pneumonia in ICU: clinical characteristics and factors influencing outcomes. [PDF]
Pneumonia (Nathan)Galli F, Forin E, Motos A, Molina Saldarriaga FJ, Gabarrus A, Canseco J, Fernandez-Barat L, Barbeta E, Calabretta D, Ceccato A, Bermejo-Martin JF, Ferrer R, Riera J, Penuelas O, Lorente JA, de Gonzalo-Calvo D, Menendez R, Gonzalez J, Palomeque A, Soler-Comas A, Amaya-Villar R, Anon JM, Marino AB, Barbera C, Barberan J, Ortiz AB, Bustamante-Munguira E, Caballero J, Canton-Bulnes ML, Perez CC, Carbonell N, Catalan-Gonzalez M, de Frutos R, Franco N, Galban C, Lago AL, Gumucio-Sanguino VD, Del Carmen de la Torre M, Diaz E, Estella A, Gallego Curto E, Garcia-Garmendia JL, Gomez JM, Huerta A, Jorge Garcia RN, Loza-Vazquez A, Marin-Corral J, Martin Delgado MC, Martinez de la Gandara A, Martinez Varela I, Lopez Messa J, Albaiceta GM, Nieto MT, Novo MA, Penasco Y, Perez-Garcia F, Pozo-Laderas JC, Ricart P, Sagredo V, Sanchez-Miralles A, Sancho Chinesta S, Roche-Campo F, Socias L, Sole-Violan J, Suarez-Sipmann F, Tamayo Lomas L, Trenado J, Ubeda A, Valdivia LJ, Vidal P, Boado MV, Rodriguez A, Ferrer M, Barbe F, Torres A, CIBERESUCICOVID Project investigators (COV20/00110, ISCIII). +76 moreeuropepmc +1 more sourceEnhancing antitumour response to proteasome inhibitors with inhibitors of insulin‐degrading enzyme, a new molecular vulnerability in multiple myeloma
British Journal of Pharmacology, EarlyView.Inhibitors of insulin‐degrading enzyme boost PI cytotoxicity through an increased sensitivity of proteasome to PI inhibitors, induction of ISR, DNA damage and Myc down‐regulation. They overcome PI resistance in vitro and induce tumour regression in vivo.Laetitia Lesire, Rebecca Deprez‐Poulain, Damien Bosc, Florence Leroux, Valerie Landry, Sarah Ourabah, Morgane Tardy, Clara Maillard, Ronan Gealageas, Julie Dumont, Adrien Herledan, Sandrine Warenghem, Manon Cruette, Celine Lenglart, Alexandre Biela, Catherine Piveteau, Eva De Smedt, Catharina Muylaert, Wenguang Liang, Elvira Garcia De Paco, Elina Alaterre, Sara Ovejero, Nicolas Robert, Fabien Delahaye, Wei‐Jen Tang, Peter van Endert, Elke De Bruyne, Jérôme Moreaux, Benoit Deprez +28 morewiley +1 more sourceLaboratory and Clinical Practices in the Study of Coeliac Disease in Children and Adults: Recommendations from a Spanish Multicentre Survey. [PDF]
NutrientsAguado R, Irure-Ventura J, Vargas ML, Roy G, Barrios Y, Martínez-Martínez L, Rodríguez B, Montes-Cano MA, López-Hoyos M, Jurado A, GEAI-SEI. +10 moreeuropepmc +1 more sourcePolarized effects of adenosine on blood–brain barrier integrity: Tightening from the luminal and opening from the abluminal side
British Journal of Pharmacology, EarlyView.Background and Purpose
Adenosine as a signalling molecule modifies blood–brain barrier (BBB) tightness in pathological conditions. Our aim was to investigate the direct and polarized effects of adenosine on the BBB using co‐culture and in vivo models. Experimental Approach
The expression of adenosine receptors was measured by qRT‐PCR.András Harazin, Gabriela Hurtado‐Alvarado, Lilla Barna, Arturo Contis‐Montes de Oca, Rocío Ruíz‐Manzano, Krisztián Laczi, András Kincses, Gergő Porkoláb, Gang Chen, Beatriz Gómez‐González, Mária A. Deli +10 morewiley +1 more sourceReal-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry. [PDF]
Lupus Sci MedVidal-Montal P, Fabregat A, Altabás-González I, Pego-Reigosa JM, Hernández-Martínez A, Rua-Figueroa I, Salman-Monte T, Moriano C, Tejera Segura B, Vela P, Pareja-Martínez A, García-Cirera S, García-Villanueva MJ, Garrote-Corral S, Heredia S, Riancho-Zarrabeitia L, Manrique-Arija S, Bernárdez J, Magallares B, Torrente-Segarra V, Frade-Sosa B, Gómez-Puerta JA, Martinez-Barrio J, Narvaez J, BELIMUMAB Multicenter Spanish Register Group (BEL-SPAIN). +24 moreeuropepmc +1 more sourceEffects of Common Food Additives Kappa‐, Iota‐ and Lambda‐Carrageenans on Intestinal Epithelial Cell Activation and Barrier Disruption
Clinical &Experimental Allergy, EarlyView.Carrageenans, widely used food additives, disrupted intestinal epithelial integrity in a gut‐on‐a‐chip model. All types (κ‐, ɩ‐, λ‐) induced cytotoxicity, inflammation and tight junction (TJ) disruption, triggering TNF‐mediated immune responses. λ‐Carrageenan had the most severe effects, supporting the Epithelial Barrier Theory linking food additives ...Na Sun, Yagiz Pat, Huseyn Babayev, Sena Ardicli, Ismail Ogulur, Xianting Bu, Manru Li, Shuqi Jia, Beate Rückert, Raja Dhir, Kari C. Nadeau, Mubeccel Akdis, Cezmi A. Akdis, Duygu Yazici +13 morewiley +1 more sourceDeciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. [PDF]
Nat CommunLangtry A, Rabadan R, Alonso L, Filip I, Sabroso-Lasa S, Moreno-Oya A, Lawlor R, Carrato A, Alvarez-Gallego R, Iglesias M, Molero X, Löhr MJ, Michalski CW, Perea J, O'Rorke M, Barberà VM, Tardón A, Farré A, Muñoz-Bellvís L, Crnogorac-Jurcevic T, Domínguez-Muñoz E, Gress TM, Greenhalf W, Sharp L, Balsells J, Costello E, Kleeff J, Kong B, Mora J, O'Driscoll D, Scarpa A, Ye W, Real FX, López de Maturana E, Malats N, PanGenEU Consortium Investigators. +35 moreeuropepmc +1 more source